Jinsi Msaada Hufanya Kazi
Kuhuisha uzoefu maalum wa duka la dawa kwa mgonjwa wetu kwa urahisishaji wa huduma kamili usio na kifani
-
1. Angalia Uthibitishaji wa Chanjo/Manufaa
Timu yetu ya watoza bili waliobobea hupata njia bora zaidi za uwasilishaji zinazopunguza gharama za nje ya mfuko.
-
2. Hamisha Maagizo kwa AmeriPharma®
Tunachakata maagizo yako kwa kufanya kazi na duka lako la dawa au daktari aliyeagiza, kufanya mabadiliko ya haraka na rahisi.
-
3. Uidhinishaji wa Awali
Timu yetu ya wataalamu hupata idhini kutoka kwa kampuni zako za bima ndani ya saa 24 hadi 72.
-
4. Msaada wa Copay & Msaada wa Kifedha
Tunapata usaidizi wa kifedha na kupunguza malipo ya nakala, gharama za nje ya mfuko, na makato mengi. Kufikia sasa, AmeriPharma® Specialty Care imepata msaada wa kifedha wa $55 milioni kwa wagonjwa wetu.
-
5. Uratibu wa Huduma ya Uuguzi Ikihitajika
AmeriPharma® hutanguliza ratiba yako na mazingira ya nyumbani unapopanga na kuratibu mmoja wa wauguzi wetu waliobobea kwa ajili ya uingilizi wako wa nyumbani.
-
6. Uratibu wa Utoaji
Dawa hutolewa kila wakati kwa kufuata madhubuti na mahitaji maalum ya usafirishaji. Uwasilishaji wa mnyororo baridi wa siku inayofuata na usiku kucha huratibiwa kulingana na ratiba yako.
What Is Fulphila?
Pegfilgrastim, which is also known by the brand name, Neulasta, is a hematopoietic agent that is used to treat neutropenia. Neulasta was the first medication produced based on the active element pegfilgrastim. Pegfilgrastim is not a hazardous drug, nor is it a form of chemotherapy.
Based on Neulasta, several different biosimilars have been produced, one of which is called Fulphila. Fulphila is similar to Neulasta in its mechanism of action, administration route, strength, and dosage.
Mechanism of Action
Pegfilgrastim is a blood cell colony-stimulating agent (CSA) and has been used successfully by cancer patients to stimulate the growth of white blood cells, more specifically neutrophils. It does this by stimulating the production of neutrophils directly from the bone marrow.
How Is Fulphila Used?
Fulphila has been approved by the Food and Drug Administration (FDA) for the treatment and prevention of (febrile) neutropenia caused by chemotherapy or radiation.
Miundo Inayopatikana
Fulphila is only available as a subcutaneous (under the skin) injection. The injection is available as a single-use prefilled syringe for subcutaneous injection at a dose of 6 mg/0.6 mL.
The injection sites can include upper areas of the buttocks, front of the thighs, lower abdomen area (2 inches away from the navel), or the upper outer arms. Do not inject into areas where the skin is tender, bruised, red, scaly, or hard, and avoid areas with scars or stretch marks. After injection, do not rub the injection site. Do not handle the prefilled syringe if you are allergic to latex, and do not save unused medication in the prefilled syringe for later use. You should not attempt to give yourself a subcutaneous injection until you have received the appropriate training from your healthcare provider.
Missed Dose
If you miss a dose, contact your physician immediately to reschedule.
Copay na Usaidizi wa Kifedha
AmeriPharma™ Specialty Pharmacy hupunguza mzigo wa kifedha kwa wagonjwa na familia zao
-
Programu ya hali ya juu hupata vyanzo vya ufadhili ili kukulinganisha na programu za msingi za dola ya juu
-
Mmoja wa wataalamu wetu wa usaidizi wa copay atasaidia katika mchakato wa kutuma maombi
-
Taarifa za kiotomatiki zitatumwa kwako na kwa daktari wako kuhusu hali ya ufadhili
Tahadhari
Unless approved by your physician, pegfilgrastim is generally not recommended for:
- Patients who have an allergy to human granulocyte colony-stimulating factors (CFS) such as filgrastim or pegfilgrastim products. The needle cap on the prefilled syringe contains natural rubber (derived from latex). Do not handle the prefilled syringe if allergic to latex. Allergic reactions can cause a rash over the whole body, shortness of breath, wheezing, dizziness, swelling around your mouth or eyes, fast heart rate, and sweating. If you have any of these symptoms, stop using Fulphila and call your doctor or get emergency help right away.
- Patients with sickle cell disorder. Using Fulphila can lead to a condition called sickle cell crisis, which may be life-threatening and require discontinuation of Fulphila.
- Patients receiving radiation therapy. Fulphila may increase the risk of developing a precancerous condition called myelodysplastic syndrome (MDS) or a type of blood cancer called acute myeloid leukemia (AML).
Fulphila Side Effects
Madhara makubwa ni pamoja na:
- Injection-site pain
- Bone and muscle aches
- Thrombocytopenia, leukocytosis
- Lung problem called acute respiratory distress syndrome (ARDS)
- Kidney injury
- Capillary leak syndrome (CLS)
- Inflammation of blood vessels
- Rupture of the spleen
Less severe side effects include:
- Sweating
- Mkojo mweusi
Bima Zimekubaliwa
Tunakubali Medicare, Medicaid ya serikali nyingi, Medi-Cal, Blue Shield, na bima nyingi za kibinafsi. Tupigie ili kujua zaidi kuhusu chanjo yako.
Anza kwa Dakika
Jaza maelezo yako na mmoja wa wataalamu wetu atakupigia simu ASAP.
Unaweza Kuokoa Kiasi Gani?
Ongea na mtaalamu wa usaidizi wa copay
(877) 778-0318
Kwa kuwasilisha, unakubali AmeriPharma's Masharti ya Matumizi, Sera ya Faragha, na Notisi ya Mbinu za Faragha
Swahili 
English 
Spanish 
Arabic 
Armenian 
Amharic 
Myanmar 
Korean 
Chinese 
Romanian 
Russian 
Tagalog 
Vietnamese 
Nepali 
Pashto